Qiagen layoffs, on the record
Every job cut, severance charge and restructuring Qiagen reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from approximately 6,000 to approximately 5,700.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 20-F for 2023 | approximately 6,000 | As of December 31, 2023 |
| 20-F for 2024 | more than 5,700 | As of December 31, 2024 |
| 20-F for 2025 | approximately 5,700 | December 31, 2025 |
Job cuts, severance and restructuring
Our summaryThe company recorded charges in 2023 related to its 2022 restructuring program, which were included in restructuring, acquisition, integration and other expenses.
Word for word“Expenses incurred in 2023 included charges related to the 2022 restructuring program, as discussed further in Note 6 "Restructuring," as well as costs related to our acquisition of Verogen, Inc. in January 2023 .” 20-F for 2023
Our summaryRestructuring, acquisition, integration and other, net expenses increased in 2024, with charges tied to the 2024 efficiency program.
Word for word“Restructuring, acquisition, integration and other, net expenses increased to $102.2 million in 2024 , or 5.2% of sales, from $35.3 million , or 1.8% of sales, in 2023 .” 20-F for 2024
Our summaryThe company recorded charges for its 2024 efficiency program, covering personnel-related costs and exit and other costs.
Word for word“Expenses incurred in 2024 included charges related to the 2024 efficiency program, as discussed further in Note 6 "Exit Costs and Impairments," as well as integration costs related to our acquisition of Verogen, Inc. in January 2023.” 20-F for 2024
Our summaryExpenses in 2023 included charges from the 2022 restructuring program.
Word for word“Expenses incurred in 2023 included charges related to the 2022 restructuring program as well as costs related to the acquisition of Verogen, Inc.” 20-F for 2024
Our summaryThe company closed its Ann Arbor, Michigan facility in 2025 after deciding to discontinue the NeuMoDx portfolio.
Word for word“Our facility in Ann Arbor, Michigan, was closed in 2025, following the decision to discontinue the NeuMoDx portfolio as discussed in Note 6 "Restructuring."” 20-F for 2025
Our summaryThe company recorded restructuring charges tied to the 2024 Efficiency Program, including inventory write-offs and intangible asset impairments, which affected gross margin.
Word for word“The gross margin in 2025 is higher compared to 2024 in part due to total restructuring charges of $295.1 million , which include $93.5 million of inventory write-offs and $133.7 million of intangible asset impairments recorded in connection with the 2024 Efficiency Program discussed in Note 6 "Restructuring."” 20-F for 2025
Our summaryThe company incurred restructuring-related expenses in 2025 for the 2024 Efficiency Program and a continuation of efficiency measures into the 2025 Restructuring Program.
Word for word“Restructuring, acquisition, integration and other net expenses decreased to $54.5 million in 2025 , or 2.6% of sales, from $102.2 million , or 5.2% of sales, in 2024 .” 20-F for 2025
| Fiscal year ended | Restructuring charges | Restructuring costs incurred |
|---|---|---|
| 2016-12-31 | $79.1 million | — |
| 2022-12-31 | — | $5 million |
| 2023-12-31 | — | $6.9 million |
Qiagen has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Qiagen’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-03-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.